Results 211 to 220 of about 354,322 (345)

Low erythropoietin to albumin ratio in the serum predicts less reversibility of renal impairment with poorer prognosis in multiple myeloma [PDF]

Ying Liu, Yanliang Bai, Xiaobo Liu, Weiya Li, Haoyan Wang, Junwei Niu, Xiaona Niu, Xingjun Xiao, Yuqing Chen, Kai Sun   +9 more
openalex   +1 more source

The Effect of Statin Use at the Time of Autologous Transplant on Response and Survival in Multiple Myeloma [PDF]

, 2008
Mehdi Hamadani, Erinn M. Hade, Don M. Benson, Craig C. Hofmeister   +3 more
openalex   +1 more source

Personalized Cancer Vaccines in the Clinical Trial Pipeline

Asia-Pacific Journal of Clinical Oncology, EarlyView.
This study analyzes the current landscape of personalized cancer vaccine clinical trials, highlighting trends in vaccine platforms, trial phases, and geographic distribution. Peptide and dendritic cell vaccines dominate early‐stage research, with promising immune responses observed in melanoma, glioblastoma, and urothelial cancer trials.
Liudmila Iamukova, Elena Alferova
wiley   +1 more source

High Implementation Adherence to Lenalidomide in Multiple Myeloma. [PDF]

Cancers (Basel)
Amitai I, Magen H, Leader A, Pironet A, Tousset E, Rozental A, De Geest S, Vaxman I, Raanani P, Nagler A.   +9 more
europepmc   +1 more source

Body mass index throughout adulthood, physical activity, and risk of multiple myeloma: A prospective analysis in three large cohorts [PDF]

, 2018
Birmann, Brenda M, Buring, Julie E, Colditz, Graham A, Giovannucci, Edward, Lee, I-Min, Marinac, Catherine R, Rebbeck, Timothy R, Rosner, Bernard A, Townsend, Mary K   +8 more
core   +1 more source

MULTIPLE MYELOMA [PDF]

BMJ, 1907
J R, Charles, H H, Sanguinetti
openaire   +2 more sources

Novel Bispecific Engagers Targeting the CεmX Domain of mIgE‐Expressing Cells

Allergy, EarlyView.
We developed bispecific TCE & NKCE targeting the CεmX domain of mIgE to eliminate IgE‐producing cells. Both constructs demonstrated potent, specific, dose‐dependent cytotoxicity and selective immune activation in vitro. These results highlight their promise as off‐the‐shelf, potentially curative therapeutics for IgE‐associated allergic diseases ...
Constantin Möller, Julia Hambach, Alessa Zoe Schaffrath, Thomas Eden, Sophia Cichutek, Anna Josephine Gebhardt, Natalie Tode, Ronald Maitschke‐Rajasekharan, Philipp Lewe, Sharon Qi, Susanne Witt, Marie Eggers, Nicola M. Tomas, Friedrich Haag, Friedrich Koch‐Nolte, Boris Fehse, Kristoffer Riecken   +16 more
wiley   +1 more source

Smoldering multiple myeloma in the United States: A population-based analysis. [PDF]

Blood Adv
Wang SY, Wang R, Schoen M, Huber JH, Feuer E, Ruhl J, Neparidze N, Ma X, Davidoff AJ, Chang SH.   +9 more
europepmc   +1 more source

Review for "Exploratory Analysis of Intensified Conditioning As First Line treatment for patients with High Risk Multiple Myeloma"

, 2020

openalex   +1 more source

Burden of haematological malignancies among children, adolescents and young adults: Global and high‐income region insights from the GBD 2021 study

British Journal of Haematology, EarlyView.
Summary This study provides a comprehensive assessment of haematological malignancies among children, adolescents and young adults aged 0–24 years, using data from the Global Burden of Disease 2021 across 204 countries from 1990 to 2021. We found that global incidence and prevalence remained relatively stable, with approximately 150 000 new cases and ...
Shujuan Xu, Baihua Yang, Xinxin Liu, Zhenshu Xu, Ping Weng   +4 more
wiley   +1 more source